|
Procept Biorobotics Corporation (NASDAQ: PRCT) |
|
Procept Biorobotics Corporation
PRCT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Procept Biorobotics growth rates, revenue grew
by 59.55 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 421
Medical Equipment & Supplies industry recorded
deterioration of revenues by -2.28 %
Procept Biorobotics net loss decreased from $-28 millions, to $-19 millions in IV. Quarter 2024,
• More on PRCT's Growth
|
|
Procept Biorobotics realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 39.34 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 13.43.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.
• More on PRCT's Valuation
|
|
|
|
|
Procept Biorobotics realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 39.34 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 13.43.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.
Procept Biorobotics Price to Book Ratio is at 7.48 higher than Industry Avg. of -156.92, and higher than S&P 500 Avg. of 0.01
• More on PRCT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com